This webinar for wAF beneficiaries will comment the first stages in technology transfer-from TRL 2 to TRL6. What should the research team do to advance their technology and prove its commercial interest? We will follow a biotech/biomed team with a promising drug candidate and other practical examples.
The webinar will answer:
- How to carry out a preliminary assessment of commercial interest. The Experimental Proof of Concept
- Keeping the secret vs. Intellectual property protection
- The Freedom to Operate analysis – will our development find external barriers?
- From validation in the Lab to validation in the field
- Finding funding: existing sources from EU grants to crowfunding
- EU instruments for specialized coaching. Connections to useful networks (eg EEN).
- Key Performance Indicators
- Market and Business Readiness: Is our product/service really suited to go to the market?
Agenda
14:00 – 14:10: Connection start & Introduction
14:10 – 14:20 Presentation of the widerAdvance Facility
14:20 – 15.30 Webinar with intermediate coffee break
15.30 – 15:55: Round table discussion
15:55 – 16:00: Wrap up
MODERATOR: Alicia Boto (CSIC)